IC Medicals: Equity Participation

Emissions of remedies

Full list of emissions of pharmaceuticals and curative plants: Actovegin, Allergy treatment, Arbidol, Deltaran, Dilacor, Esentiale, Fosamax, Liver treatment, Noni, Prednisolone, Preductal, Samprost, Soursop, Ursosan, Weight loss complex.


Встроенное изображение 2

Proposal on Internet project IC Medicals. Equity Participation

  The essence of the project 

Technology is based on five-year scientific research. Results of research show that with the help of designed innovational technology any person on the Earth using lines of communication can receive from the technical center new market product – informational (spectral) copies (ICs) of medicals drugs (and other substances) an use them together or instead of traditional methods of treatment. It is possible to use IC other areas of human activity.

Information on participation

Project was started in August 2009. The basis of the project – the practical use of natural phenomena – super weak emission (informational (spectral) copies of material media), transferring through the lines of communications. As of 01.01.2015, 2.1 millions US dollars were invested in the project.

What does project include?

1. International team of practitioners – consultants (28 persons), scientists (12 persons), managers (5 persons).

2. Conducted IN VITRO, IN VIVO research and 5039 clinical observations.

3. Technical center (Czech republic), which includes 60 informational (spectral) copies of biologically active substances for consumers and for scientific research.

4. Nine web-sites with information about IC Medicals. Including 8 web-sites www.icmedicals.com ,www.newpharm.ru , www.newpharm.bg ,www.dst-fund.ru ,www.dst-fund.com ,www.spain.newpharm.com ,www.de.newpharm.com ,www.china.newpharm.com, connected with technical center for downloading IC Medicals by consumers and scientists.

5. Applications for patenting intellectual property used in the project:

5.1. Technical Center: PCT / IB 2014 /001767. «Vorrichtung zur Fernübertragung einer repräsentierenden Größe einer von einem Material ausgesandten elektromagnetischen Strahlung und Verfahren zum Betreiben der Vorrichtung». ("Device for remote transmission of a specific parameter of electromagnetic emission, emitted by material and a method for implementing the device")

5.2. PCT/RU 2012/000033/. «Side-effect free dosage form and method for preparing some» and 2013/112066 A2 - undergoes the regionalization in Europe.

Currently there are three teams who are working on investment attraction: in the US, Europe and Russia. For now for maintaining project it is required - 15 000 euro per month. This amount is needed up to attraction of investments for the global advertising of the product. You can become an investor of this project - from each 1 euro invested in the maintenance period, you will get 10 euros of dividends. Also you can take a stake of the project, this issues is for negotiations. 

In the US, profit for 5 years according to business plan of the IC Medicals project is:
3 023 350 000 $

In Europe, profit for 5 years according to business plan of the IC Medicals project is:
1 181 294 000 Euro

In Russia, profit for 5 years according to business plan of the IC Medicals project is:
225 030 000 $.

Additional information on participation
According to our calculations maintaining project period will last no longer than 1 year.
Example of calculation for the investor:
1 certificate with value of 100 euros / month is purchased. During a year it was invested 1200 euros. Amount of your dividends will be 12 000 euros / year.

At the moment (updated 13.02.2015) it is available 147 certificates with value of 1200 euros each, which can be paid at once or 100 euros per month during a year. "

DST Fund (owner of the IC Medicals technology) signs a contract with each investor.
Each investor receives a monthly report on the development of the project.
Each investor may submit proposals on development and attract additional resources (eg, informational) to promote the project.

Contacts: dstfund@gmail.com , skype: biomset
Evgeny Germanov,
CEO of the "DST" Foundation, head of the IC Medicals project
Встроенное изображение 1

Additional materials on the project and technology:

Scientific Basis of the IC Medicals Technology. Speech of Dr.Sci.Biol VL Voeikov at the International Conference "Physics, Chemistry and Biology of Water."
  • Emission

    The essence of the “Emission” project is the possibility to transmit emission (properties) of organic and inorganic substances and biological objects remotely via communication lines using Internet addressing system.

  • Artificial Blood Substitute

    Authors of the invention: Ph.D. Biology, Candidate of Chemical Sciences, Kuznetsova Irina and Ph.D. Medicine Evgeny Maevsky. AT300 was developed on the basis of the Russian Scientific-Research Institute of Hematology and Transfusion Medicine, St. Petersburg.

  • Cancer treatment

    Dissymetric therapy (anisotropizing) tinctorial therapy (DST) – is an innovative method of oncological diseases treatment. It is based on the theory of Professor Kutushov about the causes of cancer and it's development.